Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Dec 1;360(Pt 2):481–489. doi: 10.1042/0264-6021:3600481

Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.

P S Sijwali 1, B R Shenai 1, J Gut 1, A Singh 1, P J Rosenthal 1
PMCID: PMC1222249  PMID: 11716777

Abstract

In the malaria parasite Plasmodium falciparum, erythrocytic trophozoites hydrolyse haemoglobin to provide amino acids for parasite protein synthesis. Cysteine protease inhibitors block parasite haemoglobin hydrolysis and development, indicating that cysteine proteases are required for these processes. Three papain-family cysteine protease sequences have been identified in the P. falciparum genome, but the specific roles of their gene products and other plasmodial proteases in haemoglobin hydrolysis are uncertain. Falcipain-2 was recently identified as a principal trophozoite cysteine protease and potential drug target. The present study characterizes the related P. falciparum cysteine protease falcipain-3. As is the case with falcipain-2, falcipain-3 is expressed by trophozoites and appears to be located within the food vacuole, the site of haemoglobin hydrolysis. Both proteases require a reducing environment and acidic pH for optimal activity, and both prefer peptide substrates with leucine at the P(2) position. The proteases differ, however, in that falcipain-3 undergoes efficient processing to an active form only at acidic pH, is more active and stable at acidic pH, and has much lower specific activity against typical papain-family peptide substrates, but has greater activity against native haemoglobin. Thus falcipain-3 is a second P. falciparum haemoglobinase that is particularly suited for the hydrolysis of native haemoglobin in the acidic food vacuole. The redundancy of cysteine proteases may offer optimized hydrolysis of both native haemoglobin and globin peptides. Consideration of both proteases will be necessary to evaluate cysteine protease inhibitors as antimalarial drugs.

Full Text

The Full Text of this article is available as a PDF (391.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascoli F., Fanelli M. R., Antonini E. Preparation and properties of apohemoglobin and reconstituted hemoglobins. Methods Enzymol. 1981;76:72–87. doi: 10.1016/0076-6879(81)76115-9. [DOI] [PubMed] [Google Scholar]
  2. Coulombe R., Grochulski P., Sivaraman J., Ménard R., Mort J. S., Cygler M. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 1996 Oct 15;15(20):5492–5503. [PMC free article] [PubMed] [Google Scholar]
  3. Dua M., Raphael P., Sijwali P. S., Rosenthal P. J., Hanspal M. Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1. Mol Biochem Parasitol. 2001 Aug;116(1):95–99. doi: 10.1016/s0166-6851(01)00306-1. [DOI] [PubMed] [Google Scholar]
  4. Eggleson K. K., Duffin K. L., Goldberg D. E. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J Biol Chem. 1999 Nov 5;274(45):32411–32417. doi: 10.1074/jbc.274.45.32411. [DOI] [PubMed] [Google Scholar]
  5. Francis S. E., Banerjee R., Goldberg D. E. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. J Biol Chem. 1997 Jun 6;272(23):14961–14968. doi: 10.1074/jbc.272.23.14961. [DOI] [PubMed] [Google Scholar]
  6. Francis S. E., Gluzman I. Y., Oksman A., Knickerbocker A., Mueller R., Bryant M. L., Sherman D. R., Russell D. G., Goldberg D. E. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J. 1994 Jan 15;13(2):306–317. doi: 10.1002/j.1460-2075.1994.tb06263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Francis S. E., Sullivan D. J., Jr, Goldberg D. E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol. 1997;51:97–123. doi: 10.1146/annurev.micro.51.1.97. [DOI] [PubMed] [Google Scholar]
  8. Gamboa de Domínguez N. D., Rosenthal P. J. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood. 1996 May 15;87(10):4448–4454. [PubMed] [Google Scholar]
  9. Gluzman I. Y., Francis S. E., Oksman A., Smith C. E., Duffin K. L., Goldberg D. E. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J Clin Invest. 1994 Apr;93(4):1602–1608. doi: 10.1172/JCI117140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goldberg D. E., Slater A. F., Cerami A., Henderson G. B. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2931–2935. doi: 10.1073/pnas.87.8.2931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Groves M. R., Taylor M. A., Scott M., Cummings N. J., Pickersgill R. W., Jenkins J. A. The prosequence of procaricain forms an alpha-helical domain that prevents access to the substrate-binding cleft. Structure. 1996 Oct 15;4(10):1193–1203. doi: 10.1016/s0969-2126(96)00127-x. [DOI] [PubMed] [Google Scholar]
  12. Hadley T., Aikawa M., Miller L. H. Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors. Exp Parasitol. 1983 Jun;55(3):306–311. doi: 10.1016/0014-4894(83)90027-9. [DOI] [PubMed] [Google Scholar]
  13. Karrer K. M., Peiffer S. L., DiTomas M. E. Two distinct gene subfamilies within the family of cysteine protease genes. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3063–3067. doi: 10.1073/pnas.90.7.3063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kozak M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2662–2666. doi: 10.1073/pnas.92.7.2662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kozak M. The scanning model for translation: an update. J Cell Biol. 1989 Feb;108(2):229–241. doi: 10.1083/jcb.108.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lambros C., Vanderberg J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979 Jun;65(3):418–420. [PubMed] [Google Scholar]
  17. Le Bonniec S., Deregnaucourt C., Redeker V., Banerjee R., Grellier P., Goldberg D. E., Schrével J. Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J Biol Chem. 1999 May 14;274(20):14218–14223. doi: 10.1074/jbc.274.20.14218. [DOI] [PubMed] [Google Scholar]
  18. Lyon J. A., Haynes J. D. Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface when schizonts mature in the presence of protease inhibitors. J Immunol. 1986 Mar 15;136(6):2245–2251. [PubMed] [Google Scholar]
  19. Nakai K., Kanehisa M. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics. 1992 Dec;14(4):897–911. doi: 10.1016/S0888-7543(05)80111-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pasquier C., Promponas V. J., Palaios G. A., Hamodrakas J. S., Hamodrakas S. J. A novel method for predicting transmembrane segments in proteins based on a statistical analysis of the SwissProt database: the PRED-TMR algorithm. Protein Eng. 1999 May;12(5):381–385. doi: 10.1093/protein/12.5.381. [DOI] [PubMed] [Google Scholar]
  21. Raphael P., Takakuwa Y., Manno S., Liu S. C., Chishti A. H., Hanspal M. A cysteine protease activity from Plasmodium falciparum cleaves human erythrocyte ankyrin. Mol Biochem Parasitol. 2000 Oct;110(2):259–272. doi: 10.1016/s0166-6851(00)00283-8. [DOI] [PubMed] [Google Scholar]
  22. Rosenthal P. J., Lee G. K., Smith R. E. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J Clin Invest. 1993 Mar;91(3):1052–1056. doi: 10.1172/JCI116262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rosenthal P. J., McKerrow J. H., Aikawa M., Nagasawa H., Leech J. H. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J Clin Invest. 1988 Nov;82(5):1560–1566. doi: 10.1172/JCI113766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rosenthal P. J., Meshnick S. R. Hemoglobin catabolism and iron utilization by malaria parasites. Mol Biochem Parasitol. 1996 Dec 20;83(2):131–139. doi: 10.1016/s0166-6851(96)02763-6. [DOI] [PubMed] [Google Scholar]
  25. Rosenthal P. J., Nelson R. G. Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. Mol Biochem Parasitol. 1992 Mar;51(1):143–152. doi: 10.1016/0166-6851(92)90209-3. [DOI] [PubMed] [Google Scholar]
  26. Rosenthal P. J., Wollish W. S., Palmer J. T., Rasnick D. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J Clin Invest. 1991 Nov;88(5):1467–1472. doi: 10.1172/JCI115456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Salas F., Fichmann J., Lee G. K., Scott M. D., Rosenthal P. J. Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect Immun. 1995 Jun;63(6):2120–2125. doi: 10.1128/iai.63.6.2120-2125.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Salmon B. L., Oksman A., Goldberg D. E. Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):271–276. doi: 10.1073/pnas.011413198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Saul A., Battistutta D. Analysis of the sequences flanking the translational start sites of Plasmodium falciparum. Mol Biochem Parasitol. 1990 Aug;42(1):55–62. doi: 10.1016/0166-6851(90)90112-y. [DOI] [PubMed] [Google Scholar]
  30. Saul A., Battistutta D. Codon usage in Plasmodium falciparum. Mol Biochem Parasitol. 1988 Jan 1;27(1):35–42. doi: 10.1016/0166-6851(88)90022-9. [DOI] [PubMed] [Google Scholar]
  31. Shenai B. R., Sijwali P. S., Singh A., Rosenthal P. J. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J Biol Chem. 2000 Sep 15;275(37):29000–29010. doi: 10.1074/jbc.M004459200. [DOI] [PubMed] [Google Scholar]
  32. Sijwali P. S., Brinen L. S., Rosenthal P. J. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2. Protein Expr Purif. 2001 Jun;22(1):128–134. doi: 10.1006/prep.2001.1416. [DOI] [PubMed] [Google Scholar]
  33. Sipos L., von Heijne G. Predicting the topology of eukaryotic membrane proteins. Eur J Biochem. 1993 May 1;213(3):1333–1340. doi: 10.1111/j.1432-1033.1993.tb17885.x. [DOI] [PubMed] [Google Scholar]
  34. Thompson J. D., Higgins D. G., Gibson T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994 Nov 11;22(22):4673–4680. doi: 10.1093/nar/22.22.4673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES